$Tempus AI(TEM)$ Tempus AI com

Like
Comment
Favorite

$Tempus AI(TEM)$ Tempus AI completes its acquisition of Ambry Genetics, a provider of genetic testing As previously disclosed in Tempus'' third quarter 2024 results, the company paid $375 million in cash and $225 million in shares at closing, of which $100 million is subject to a lock-up agreement until one year post-transaction close. Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":399846521155760,"tweetId":"399846521155760","gmtCreate":1738643695665,"gmtModify":1738643702034,"author":{"id":10000000000011024,"idStr":"10000000000011024","authorId":10000000000011024,"authorIdStr":"10000000000011024","name":"Astrid Stephen","avatar":"https://static.tigerbbs.com/1647de40d206ee3288442d8c4170cfa0","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":46,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p> <a data-mention-id=\"TEM\" class=\"teditor-mention\" data-mention-name=\"Tempus AI\" href=\"https://ttm.financial/S/TEM\">$Tempus AI(TEM)$</a> <v-v data-views=\"1\"></v-v>Tempus AI completes its acquisition of Ambry Genetics, a provider of genetic testing As previously disclosed in Tempus'' third quarter 2024 results, the company paid $375 million in cash and $225 million in shares at closing, of which $100 million is subject to a lock-up agreement until one year post-transaction close. Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team.</p></body></html>","htmlText":"<html><head></head><body><p> <a data-mention-id=\"TEM\" class=\"teditor-mention\" data-mention-name=\"Tempus AI\" href=\"https://ttm.financial/S/TEM\">$Tempus AI(TEM)$</a> <v-v data-views=\"1\"></v-v>Tempus AI completes its acquisition of Ambry Genetics, a provider of genetic testing As previously disclosed in Tempus'' third quarter 2024 results, the company paid $375 million in cash and $225 million in shares at closing, of which $100 million is subject to a lock-up agreement until one year post-transaction close. Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team.</p></body></html>","text":"$Tempus AI(TEM)$ Tempus AI completes its acquisition of Ambry Genetics, a provider of genetic testing As previously disclosed in Tempus'' third quarter 2024 results, the company paid $375 million in cash and $225 million in shares at closing, of which $100 million is subject to a lock-up agreement until one year post-transaction close. Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/399846521155760","repostId":0,"isVote":1,"tweetType":1,"viewCount":359,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TEM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":431,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}